Treatment of Achalasia — From Whalebone to Botulinum Toxin
- 23 March 1995
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 332 (12) , 815-816
- https://doi.org/10.1056/nejm199503233321211
Abstract
Achalasia, described by Thomas Willis in 1674, was initially treated by dilation of the lower esophagus with a whalebone. The forceful disruption of the lower esophagus by this means relieved dysphagia and other obstructive symptoms. Current procedures, pneumatic balloon dilation and surgical myotomy of the lower esophageal sphincter, mimic this earlier approach. The relative merits of these treatments have been debated without resolution for more than 40 years. Pneumatic dilation and myotomy result in long-term relief of dysphagia in 70 and 85 percent of patients, respectively.1 In 5 percent of patients, pneumatic dilation causes esophageal perforation, requiring subsequent thoracic surgical . . .Keywords
This publication has 9 references indexed in Scilit:
- Intrasphincteric Botulinum Toxin for the Treatment of AchalasiaNew England Journal of Medicine, 1995
- Treatment of Achalasia in Chagas' Disease with Botulinum ToxinNew England Journal of Medicine, 1995
- Treatment of Achalasia with Intrasphincteric Injection of Botulinum Toxin: A Pilot TrialAnnals of Internal Medicine, 1994
- Treatment of Dysfunction of the Cricopharyngeal Muscle with Botulinum a Toxin: Introduction of a New, Noninvasive MethodAnnals of Otology, Rhinology & Laryngology, 1994
- Effects of intrasphincteric botulinum toxin on the lower esophageal sphincter in pigletsGastroenterology, 1993
- Therapeutic Uses of Botulinum ToxinNew England Journal of Medicine, 1991
- AchalasiaGastroenterology Clinics of North America, 1989
- TREATMENT OF ANISMUS IN INTRACTABLE CONSTIPATION WITH BOTULINUM A TOXINThe Lancet, 1988
- Integrity of cholinergic innervation to the lower esophageal sphincter in achalasiaGastroenterology, 1986